Study Evaluating SARS-CoV-2 (COVID-19) Humoral Response After BNT162b2 Vaccine in Immunocompromised Adults Compared to Healthy Adults

Name: Study Evaluating SARS-CoV-2 (COVID-19) Humoral Response After BNT162b2 Vaccine in Immunocompromised Adults Compared to Healthy Adults
Published: 2021
License: Public Domain

Centre Hospitalier Régional d'Orléans · 2021

ClinicalTrials.gov · Datasets · License: Public Domain · 2021

Open Source ↗

antibody cancer hiv multiple-sclerosis sars-cov-2

kidney transplant, myeloma, cancer, hematologic malignancy, multiple sclerosis, hypergammaglobulinemia, malignant tumor, hiv, diabetes type 2, sars-cov-2, bnt162b2 vaccine, antibody

This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

Record · ID 861752
Retrieved via Conceptio — every document is proof-bundled with source, license, and retrieval metadata.